Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Active, not recruiting

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

NCT06068075

Conditions
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Active, not recruiting

Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma

NCT02914405

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital Madison, Wisconsin, United States
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, not recruiting

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

NCT02573896

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States
  • University of Chicago Comer Children's Hospital Chicago, Illinois, United States
View Trial Details
Active, not recruiting

Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma

NCT02298348

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details

Related conditions